Sensus Healthcare, Inc.

NCM: SRTS
Live Quote

📈 ZcoreAI Score

Our AI model analyzes Sensus Healthcare, Inc.'s price action across multiple timeframes using regression channels and statistical scoring.

Get SRTS Z-Score →

About Sensus Healthcare, Inc.

Healthcare Medical Devices
Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 +; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, such as applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos, as well as provide operational healthcare services for dermatology clinics. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. The company was incorporated in 2010 and is based in Boca Raton, Florida.

📊 Fundamental Analysis

Sensus Healthcare, Inc. demonstrates a profit margin of -28.1%, which is below the sector average, suggesting competitive pressure.

The company recently reported -62.2% revenue growth, which is negative, indicating a recent decline in revenue.

Return on Equity (ROE) is -14.9%, which indicates that capital utilization is currently under pressure.

At a current price of $4.49, SRTS currently sits at the 51st percentile of its 52-week range (Range: $3.03 - $5.92).

🏥 Financial Health

🔴 Profit Margin Weak
🔴 Debt/Equity Elevated
🔴 Revenue Growth Weak
🔴 Return on Equity Weak
⚠️ Beta (Risk) Moderate Volatility

Key Financials

Market Cap
$73.91M
Trailing P/E
--
Forward P/E
70.90
Beta (5Y)
1.28
52W High
$5.92
52W Low
$3.03
Avg Volume
82K
Day High
Day Low
Get SRTS Z-Score on Dashboard 🚀